# RYZODEG 70/30
> **BLA203313** · Biologics License Application · Sponsor: NOVO · Approved 2015-09-25
## Drug
- **FDA Application Number:** BLA203313
- **Application type:** Biologics License Application
- **Brand name:** RYZODEG 70/30
- **Generic name:** Insulin Aspart
- **Active ingredients:** INSULIN ASPART; INSULIN DEGLUDEC
- **Dosage form:** SOLUTION
- **Route:** SUBCUTANEOUS
- **Marketing status:** Discontinued
- **Sponsor:** NOVO
- **First approval:** 2015-09-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203313)
---
*MORVS · CC0 1.0*